0001140361-21-022547.txt : 20210628
0001140361-21-022547.hdr.sgml : 20210628
20210628170809
ACCESSION NUMBER: 0001140361-21-022547
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210624
FILED AS OF DATE: 20210628
DATE AS OF CHANGE: 20210628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DESOUZA ERROL B
CENTRAL INDEX KEY: 0001213895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38787
FILM NUMBER: 211054411
MAIL ADDRESS:
STREET 1: 215 COLLEGE ROAD
CITY: PARAMUS
STATE: NJ
ZIP: 07652
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001755237
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831895370
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4.xml
FORM 4
X0306
4
2021-06-24
0001755237
Cyclerion Therapeutics, Inc.
CYCN
0001213895
DESOUZA ERROL B
C/O CYCLERION THERAPEUTICS, INC.
245 FIRST STREET, 18TH FLOOR
CAMBRIDGE
MA
02142
true
Stock Option (Right to Buy)
3.97
2021-06-24
4
A
0
10000
0
A
2031-06-24
Common Stock
10000
10000
D
The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.
/s/ Gary J. Simon, Attorney-in-Fact
2021-06-28